Compare QTRX & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | MRLN |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 172.8M |
| IPO Year | 2017 | 2024 |
| Metric | QTRX | MRLN |
|---|---|---|
| Price | $3.29 | $1.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $3.00 | ★ $7.92 |
| AVG Volume (30 Days) | 903.2K | ★ 3.6M |
| Earning Date | 11-09-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,632,000.00 | N/A |
| Revenue This Year | $3.55 | $9.23 |
| Revenue Next Year | $10.02 | $153.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 64.52 | N/A |
| 52 Week Low | $2.15 | $1.22 |
| 52 Week High | $8.77 | $17.00 |
| Indicator | QTRX | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.64 | 23.26 |
| Support Level | $2.89 | N/A |
| Resistance Level | $3.74 | $3.45 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 26.84 | 4.07 |
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.